KYMIRA Sport

United Kingdom
Reading, England, United Kingdom, RG6 6BZ

Company profile

KYMIRA Sport company profile

Established in 2013 in the renowned Science and Technology labs at the University of Reading, Their combined team of Scientists and Sport’s enthusiasts have developed a range of performance and recovery enhancing sportswear that incorporates their unique, patented KYnergy infrared technology. Their KYnergy technology uses the textile Celliant to recycle the body's waste energy back for the benefit of the wearer, to enhance performance and accelerate recovery processes. They designed and engineered their specialist sportswear to work harder for you, so you can perform at your MAXIMUM potential. KYMIRA Sport products have been designed specifically with the purpose of enhancing performance and accelerating recovery. With their inbuilt KYnergy infrared technology embedded within the fibres of their fabrics, your body gains from the following responses that occur when you are exposed to infrared. click on the PROVEN benefits below to find out exactly how the magic happens! Using their KYnergy infrared technology causes an increase in a molecule called Nitric Oxide (NO) which is a vasodilator. This means that NO causes your blood vessels to expand, allowing more blood to pass through them Putting it simply, using their KYnergy infrared technology means that your muscles have more fuel available and work more efficiently. Breaking this down, because your circulation is increased, more oxygen is delivered to the muscle cells (more fuel). There isn't a simple way to explain this, but in short: when you use KYMIRA kit, the infrared causes NO to dissociate from the active site of one of the enzyme Cytochrome-C Oxidase which is part of the energy production process within your cells. Because the active site is free, the metabolic processes within your cells occur quicker resulting in a number of further responses: increased energy (ATP) production and cells grow, repair & replicate quicker. Finally studies have found that using their technology will alleviate pain because as well as acting as a vasodilator, NO also reacts with a molecule called cyclic Guanosine Monophosphate (cGMP) which then mediates a pain relief response. The NO & cGMP reaction is actually the same way that taking an opiate like morphine works, but infrared is a lot less potent.

Business identity

Contact email
[email protected]
Phone number
+441189357224
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0+
Founded
2013-04-16

Headquarters

Postal code
RG6 6BZ
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
3
Total equity funding
$539,780
Last funding
Seed / 2019-04-19
Last equity funding
Seed
Investors
2
Lead investors
1
Founders
1
Articles
1

Founders and investors

Founders

Timothy Brownstone

Lead investors

Henley Business Angels

Investors

Actions Capital (fka K50 Ventures)Henley Business Angels